I have to agree with this. On the other hand, they are taking action now or it may have been the plan all along. The lower SC6 pricing this quarter is probably also forced their hand.
At least this way, the company has a future.
Haplo
- Forums
- ASX - By Stock
- PLS
- Pilbara to double and triple down, where will the money come from?
Pilbara to double and triple down, where will the money come from?, page-36
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.07 |
Change
0.090(3.02%) |
Mkt cap ! $9.197B |
Open | High | Low | Value | Volume |
$3.05 | $3.09 | $3.02 | $74.82M | 24.46M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 750 | $3.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.07 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 750 | 3.050 |
2 | 44802 | 3.040 |
7 | 195289 | 3.030 |
12 | 445998 | 3.020 |
5 | 26550 | 3.010 |
Price($) | Vol. | No. |
---|---|---|
3.080 | 227736 | 15 |
3.090 | 254756 | 21 |
3.100 | 787128 | 86 |
3.110 | 72903 | 13 |
3.120 | 185976 | 25 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
PLS (ASX) Chart |